via Mad In America;
J&J Asks To Keep Risperdal Studies Under Seal
December 3, 2013
Law 360 reports that Johnson & Johnson asked a Pennsylvania judge to keep a series of clinical studies related to the drug Risperdal under seal, saying that the plaintiffs were improperly seeking to publicly release them.
This entry was posted in Antipsychotics, Featured News, In the News, Industry, Psychiatric Drugs byKermit Cole. Bookmark the permalink.
Related Posts:
Thank You Mr Cole and MIA.
And just One of our personal favorites:
Read the popcorn bling.
No way in Hell the people peddling Risperdal are going to ingest it themselves and become, "Mentally Healthy".
And they're so brilliant they need to be Assured BY the Sales Rep that the popcorn is Safe for THEM to consume.
So much for its effect of inducing a state of "Health", Mental or Otherwise.
No comments:
Post a Comment